TABLE 4.
Differences in the Occurrence of COPD Exacerbations 6 Months Preand Postconversion from Fluticasone/Salmeterol to Mometasone/Formoterol
| Mometasone/formoterola | ||||
|---|---|---|---|---|
| Exacerbation | No exacerbation | Tot al | ||
| Fluticasone/salmeterolb | Exacerbation, n | 80 | 98 | 178 |
| No exacerbation, n | 69 | 274 | 343 | |
| Total | 149 | 372 | 521 | |
Note: P = 0.030.
a Postconversion.
b Preconversion.
COPD = chronic obstructive pulmonary disease